BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2300478
,
CXCL2
,
nitric oxide metabolic process
,
Ischemia
,
Hippocampus
,
Tamoxifen
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CC 1
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Hypoxia-induced gene expression in chemoradioresistant cervical cancer
L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Chemokine CCL14 affected the clinical outcome and correlated with immune infiltrates in thyroid carc…
External validation of urinary C-C motif chemokine ligand 14 (CCL14) for prediction of persistent ac…
CCL14 exacerbates intraplaque vulnerability by promoting neovascularization in the human carotid pla…
Performance of urinary C-C motif chemokine ligand 14 for the prediction of persistent acute kidney i…
Glycosylation Regulates N-Terminal Proteolysis and Activity of the Chemokine CCL14.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
the Bispecific PSMAxCD3 Antibody CC-1 in Patients With Castration Resistant Prostate Carcinoma
Bispecific PSMAxCD3 Antibody CC-1 in Patients With Squamous Cell Carcinoma of the Lung
Antibody CC-1 in Men With Biochemical Recurrence of Prostate Cancer
SI + CC Versus 3:1 C:V Ratio During Neonatal CPR
Open-label Extended Access Program on Lenalidomide Plus Dexamethasone in Chinese Subjects With Relap…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ